WAT News and Press, Waters Corporation From 09/26/23

2023-09-26 16:14:57 ET Summary Demand from biopharmas for life sciences equipment has not sustained high expectations in 2023, leading to weaker growth and negative revisions for companies like Agilent. Biopharma and industrial companies have significantly pulled back on spending ...

Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies PR Newswire News Summary: New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scatterin...

2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...

2023-09-14 21:02:10 ET Waters Corporation (WAT) Bank of America Global Healthcare Conference 2023 Call September 13, 2023 08:20 AM ET Company Participants Udit Batra - President and Chief Executive Officer Conference Call Participants Derik De Bruin - Bank of...

2023-09-13 00:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media PR Newswire News Summary: Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccor...

2023-09-04 08:07:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here’s a look at 3 leading robo-lab company stocks. When you think of dexterous professions, you often think of doctors or musicians. You may not think of scientists, but scientists need...

2023-09-03 10:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-09-03 09:03:12 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-09-01 09:06:06 ET More on Illumina Illumina, Inc. ( ILMN ) UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript) Illumina, Inc. 2023 Q2 - Results - Earnings Call Presentation Illumina, Inc.: Collapsing Margins, Rising Debt, Legal Setbacks, And ...